| CRISPR technology: The engine that drives cancer therapy M Zhang, EA Eshraghian, O Al Jammal, Z Zhang, X Zhu Biomedicine & pharmacotherapy 133, 111007, 2021 | 50 | 2021 |
| A review of constituents identified in e-cigarette liquids and aerosols EA Eshraghian, WK Al-Delaimy Tobacco prevention & cessation 7, 2021 | 47 | 2021 |
| The impact of human mobility on regional and global efforts to control HIV transmission EA Eshraghian, SN Ferdos, SR Mehta Viruses 12 (1), 67, 2020 | 17 | 2020 |
| Results from first-in-human clinical trial of RP-A501 (AAV9: LAMP2B) gene therapy treatment for Danon disease B Greenberg, E Eshraghian, P Battiprolu, D Ricks, P Yarabe, J Schwartz, ... Circulation 144 (Suppl_1), A10727-A10727, 2021 | 15 | 2021 |
| International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review KN Hong, EA Eshraghian, M Arad, A Argirò, M Brambatti, Q Bui, O Caspi, ... Journal of the American College of Cardiology 82 (16), 1628-1647, 2023 | 14 | 2023 |
| Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction A Brann, J Miller, E Eshraghian, JJ Park, B Greenberg European Journal of Heart Failure 25 (10), 1755-1765, 2023 | 14 | 2023 |
| Extracellular RNA as a kind of communication molecule and emerging cancer biomarker D Wu, T Tao, EA Eshraghian, P Lin, Z Li, X Zhu Frontiers in Oncology 12, 960072, 2022 | 14 | 2022 |
| Mortality prediction in patients with or without heart failure using a machine learning model SY Jang, JJ Park, E Adler, E Eshraghian, FS Ahmad, C Campagnari, ... JACC: Advances 2 (7), 100554, 2023 | 4 | 2023 |
| Extended Results From First-In-Human Clinical Trial Of RP-A501 (AAV9: LAMP2B) Gene Therapy Treatment For Danon Disease B Greenberg, J Rossano, S Epstein, P Battiprolu, MA Urey, N Hong, ... American Society of Gene and Cell Therapy–25th Annual Meeting, 2022 | 2 | 2022 |
| An International Longitudinal Natural History Study of Danon Disease Patients: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes K Hong, EA Eshraghian, T Khedro, A Argirò, J Attias, GR Storm, M Tsotras, ... medRxiv, 2024.05. 21.24307720, 2024 | | 2024 |
| A Retrospective Natural History Study of Danon Disease KN Hong, T Khedro, E Eshraghian, J Attias, G Storm, M Tsotras, I Jackson, ... Circulation 148 (Suppl_1), A14213-A14213, 2023 | | 2023 |
| QUALITY OF LIFE ASSESSMENT IN PATIENTS WITH DANON DISEASE E Margolin, KN Hong, E Eshraghian, J Attias, MA Urey, E Adler Journal of the American College of Cardiology 79 (9_Supplement), 519-519, 2022 | | 2022 |
| THE IMPORTANCE OF NATURAL HISTORY DATA COLLECTION AS DEMONSTRATED IN DANON DISEASE ECHOCARDIOGRAM ANALYSIS G Storm, K Boynton, A Barnard, E Eshraghian, K Hong, L Mestroni, ... JOURNAL OF INVESTIGATIVE MEDICINE 70 (1), 119-119, 2022 | | 2022 |
| Is Muscle Density an Effect Modifier in the BMI-Mortality Relationship? EA Eshraghian University of California, San Diego, 2020 | | 2020 |
| Attenuation of Drug-Primed Reinstatement by α3β4 nAChR Antagonism is Less Potent in Animals that Self-Administer CSE than Nicotine EA Eshraghian | | |
